Literature DB >> 1476191

Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum.

J F Tack1, J Janssens, G Vantrappen, J D Wood.   

Abstract

Intracellular recording methods were used to study the actions of 5-hydroxytryptamine (5-HT) on 257 myenteric neurons in the guinea pig gastric antrum. Application of 5-HT caused three types of postsynaptic responses. A fast-activating depolarizing response was accompanied by a decreased input resistance and desensitized quickly to repeated applications. It was mediated by a 5-HT3 receptor. A slowly activating depolarization, accompanied by an increase in the input resistance and enhancement of the excitability, was mainly observed in after hyperpolarizing/type 2 neurons. It was suppressed by the prokinetic benzamide compound renzapride, while classical 5-HT1-4 receptor antagonists had no effect, suggesting the involvement of a 5-HT1p receptor as described in small intestinal neurons. A long-lasting hyperpolarizing response, accompanied by a decreased input resistance, was observed in a small subset of neurons. This response seemed to be mediated by a 5-HT1a receptor. Superfusion of 5-HT caused a dose-dependent inhibition of the stimulus-evoked nicotinic cholinergic fast excitatory postsynaptic potential (EPSP), which was mediated by a presynaptic 5-HT1a receptor. 5-HT also presynaptically inhibited the slow EPSP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1476191     DOI: 10.1152/ajpgi.1992.263.6.G838

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Functional Dyspepsia: Impaired Fundic Accommodation.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

2.  Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E.

Authors:  Johannes Kapeller; Dorothee Möller; Felix Lasitschka; Frank Autschbach; Ruud Hovius; Gudrun Rappold; Michael Brüss; Michael D Gershon; Beate Niesler
Journal:  J Comp Neurol       Date:  2011-02-15       Impact factor: 3.215

Review 3.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Roles of Non-cholinergic Intrapancreatic Nerves, Serotonergic Nerves, on Pancreatic Exocrine Secretion in the Isolated Perfused Rat Pancreas.

Authors:  Zheng Er Jiang; Bich-Na Shin; In-Hye Kim; Hyun Joo Lee; Jun-Hwan Yong; Min-Jae Lee; Moo-Ho Won; Yun-Lyul Lee
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

5.  Buspirone, a new drug for the management of patients with ineffective esophageal motility?

Authors:  Charlotte Scheerens; Jan Tack; Nathalie Rommel
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

Review 6.  Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

Authors:  Gary M Mawe; Jill M Hoffman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-25       Impact factor: 46.802

7.  In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs.

Authors:  P Janssen; N H Prins; B Moreaux; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 9.  Neuropathophysiology of functional gastrointestinal disorders.

Authors:  Jackie D Wood
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

Review 10.  Serotonergic modulation of visceral sensation: upper gastrointestinal tract.

Authors:  J Tack; G Sarnelli
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.